The move comes as companies including Torrent Pharmaceuticals, Glenmark Pharmaceuticals and Sun Pharmaceutical Industries introduced semaglutide formulations in the Indian market following the expiry of patent protection on March 21.Read More
The move comes as companies including Torrent Pharmaceuticals, Glenmark Pharmaceuticals and Sun Pharmaceutical Industries introduced semaglutide formulations in the Indian market following the expiry of patent protection on March 21.Read More